Publications by EPC members and groups affiliated with the EPC and its sister societies can be downloaded below:


Participant and Faculty Publications

One of the pillars of the Pancreas 2000 program is to work in a project group and conduct scientific research and/or a clinical trial, which ideally ends in a publication. Below you will find a list of papers that were published as a direct result of the Pancreas 2000 program.

Moreover, the Pancreas 2000 program has led to more publications in the field of Pancreatology overall. Based on a search conducted in 2018, course graduates have published over 2,523 articles relating to the pancreas, thereby making an important contribution to the further development of this important specialty.

Pancreatic Cancer

In the Era of the Leeds Protocol: A Systematic Review and a Meta-Analysis on the Effect of Resection Margins on Survival Among Pancreatic Ductal Adenocarcinoma Patients Kurlinkus B, Ahola R, Zwart E, Halimi A, Yilmaz BS, Ceyhan GO, Laukkarinen J. Scand J. Surg. 2020 Mar;109(1):11-17.

Risk of Malignancy in Resected Pancreatic Mucinous Cystic Neoplasms Keane MG, Shamali A, Nilsson LN, Antila A, Millastre Bocos J, Marijinissen Van Zanten M, Verdejo Gil C, Maisonneuve P, Vaalavuo Y, Hoskins T, Robinson S, Ceyhan GO, Abu Hilal M, Pereira SP, Laukkarinen J, Del Chiaro M Br J Surg. 2018 Mar;105(4):439-446. doi: 10.1002/bjs.10787.

Real-World Clinical Practice of Intensified Chemotherapies for Metastatic Pancreatic Cancer: Results From A Pan-European Questionnaire Study Le N, Vinci A, Schober M, Krug S, Javed MA, Kohlmann T, Sund M, Neesse A, Beyer G Digestion. 2016;94(4):222-229. doi: 10.1159/000453257. Epub 2016 Dec 29.

Prognostic and Predictive Markers in Pancreatic Adenocarcinoma Le N, Sund M, Vinci A; GEMS Collaborating Group of Pancreas 2000 Dig Liver Dis. 2016 Mar;48(3):223-30. doi: 10.1016/j.dld.2015.11.001. Epub 2015 Nov 14.

Nature and Management of Pancreatic Mucinous Cystic Neoplasm (MCN): A Systematic Review of the Literature Nilsson LN, Keane MG, Shamali A, Millastre Bocos J, Marijinissen van Zanten M, Antila A, Verdejo Gil C, DelChiaro M, Laukkarinen J. Pancreatology. 2016 Nov - Dec;16(6):1028-1036. doi: 10.1016/j.pan.2016.09.011. Epub 2016 Sep 20.

New Advances in the Treatment of Metastatic Pancreatic Cancer
Schober M, Javed MA, Beyer G, Le N, Vinci A, Sund M, Neesse A, Krug S
Digestion. 2015;92(3): 175-84

Increased Incidence of Extrapancreatic Neoplasms in Patients with IPMN: Fact or Fiction? A Critical Systematic Review
Pugliese L, Keskin M, Maisonneuve P, D'Haese JG, Marchegiani G, Wenzel P, Del Chiaro M, Ceyhan GO.
Pancreatology. 2015 May-Jun; 15(3):209-16/j.pan.2015.03.007. Epub 2015 Mar 18. 

Association Between Pancreatic Intraductal Papillary Mucinous Neoplasms and Extrapancreatic Malignancies 
Marchegiani G, Malleo G, D'Haese JG, Wenzel P, Keskin M, Pugliese L, Borin A, Benning V, Nilsson L, Oruc N, Segersvard R, Friess H, Schmid R, Löhr M, Maisonneuve P, Bassi C, Ceyhan GO, Salvia R, Del Chiaro M. 
Clin Gastroenterol Hepatol 2015 Jun; 13(6): 1162-9. doi. 10.1016/j.cgh.2014.11.029. Epub 2014 Dec 2.

Influence of Cachexia and Sarcopenia on Survival in Pancreatic Ductal Adenocarcinoma: A Systematic Review Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, Charnley RM, Lyadov V Pancreatology. 2015 Jan-Feb;15(1):19-24. doi: 10.1016/j.pan.2014.11.006. Epub 2014 Dec 4.

Pancreaticduodenectomy for Peri-Ampullary Neoplasia Leads to Specific Micronutrient Deficiencies Armstrong T, Strommer L, Ruiz-Jasbon F, Shek FW, Harris SF, Permert J, Johnson CD Pancreatology. 2007;7(1):37-44. Epub 2007 Apr 18.

Does Anyone Survive Pancreatic Ductal Adenocarcinoma? A Nationwide Study Re-Evaluating the Data of the Finnish Cancer Registry Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, Haglund C. Gut. 2005 Mar;54(3):385-7.



HaPanEU Chronic Pancreatitis Guidelines

There have been substantial improvements in the management of chronic pancreatitis, leading to the publication of several national guidelines during recent years. In collaboration with United European Gastroenterology, the working group on ‘Harmonizing diagnosis and treatment of chronic pancreatitis across Europe’ (HaPanEU) developed these European guidelines using an evidence-based approach.


IgG4-Related Digestive Disease

The overall objective of these guidelines is to provide evidence-based recommendations for the diagnosis and management of immunoglobulin G4 (IgG4)-related digestive disease in adults and children